116. Zaahl, M.G.; Robson, K.J.; Warnich, L.; Kotze, M.J. Expression of the SLC11A1 (NRAMP1) 5'-(GT)n repeat: Opposite effect in the presence of -237C→T. *Blood Cells Mol. Dis.* **2004**, *33*, 45-50. [CrossRef] [PubMed]

117. Taka, S.; Gazouli, M.; Politis, P.K.; Pappa, K.I.; Anagnou, N.P. Transcription factor ATF-3 regulates allele variation phenotypes of the human SLC11A1 gene. *Mol. Biol. Rep.* **2012**, *40*, 2263-2271. [CrossRef] [PubMed]

118. Mass, E.; Ballesteros, I.; Farlik, M.; Halbritter, F.; Gunther, P.; Crozet, L.; Jacome-Galarza, C.E.; Handler, K.; Klughammer, J.; Kobayashi, Y.; et al. Specification of tissue-resident macrophages during organogenesis. *Science* **2016**, *353*, aaf4238. [CrossRef] [PubMed]

119. Gosselin, D.; Link, V.M.; Romanoski, C.E.; Fonseca, G.J.; Eichenfield, D.Z.; Spann, N.J.; Stender, J.D.; Chun, H.B.; Garner, H.; Geissmann, F.; et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. *Cell* **2014**, *159*, 1327-1340. [CrossRef] [PubMed]

120. Lavin, Y.; Winter, D.; Blecher-Gonen, R.; David, E.; Keren-Shaul, H.; Merad, M.; Jung, S.; Amit, I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. *Cell* **2014**, *159*, 1312-1326. [CrossRef] [PubMed]

121. Jha, A.K.; Huang, S.C.; Sergushichev, A.; Lampropoulou, V.; Ivanova, Y.; Loginicheva, E.; Chmielewski, K.; Stewart, K.M.; Ashall, J.; Everts, B.; et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. *Immunity* **2015**, *42*, 419-430. [CrossRef] [PubMed]

122. Kelly, B.; O'Neill, L.A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. *Cell Res.* **2015**, *25*, 771-784. [CrossRef] [PubMed]

123. Cellier, M.F.; Courville, P.; Campion, C. Nramp1 phagocyte intracellular metal withdrawal defense. *Microbes Infect.* **2007**, *9*, 1662-1670. [CrossRef] [PubMed]

124. Brown, J.D.; Lin, C.Y.; Duan, Q.; Griffin, G.; Federation, A.J.; Paranal, R.M.; Bair, S.; Newton, G.; Lichtman, A.H.; Kung, A.L.; et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. *Mol. Cell* **2014**, *56*, 219-231. [CrossRef] [PubMed]

125. Peeters, J.G.; Vervoort, S.J.; Tan, S.C.; Mijnheer, G.; de Roock, S.; Vastert, S.J.; Nieuwenhuis, E.E.; van Wijk, F.; Prakken, B.J.; Creyghton, M.P.; et al. Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression. *Cell Rep.* **2015**, *12*, 1986-1996. [CrossRef] [PubMed]

126. Roe, J.S.; Mercan, F.; Rivera, K.; Pappin, D.J.; Vakoc, C.R. BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia. *Mol. Cell* **2015**, *58*, 1028-1039. [CrossRef] [PubMed]

127. Quang, D.X.; Erdos, M.R.; Parker, S.C.; Collins, F.S. Motif signatures in stretch enhancers are enriched for disease-associated genetic variants. *Epigenet. Chromatin* **2015**, *8*, 23. [CrossRef] [PubMed]

128. Novakovic, B.; Habibi, E.; Wang, S.Y.; Arts, R.J.; Davar, R.; Megchelenbrink, W.; Kim, B.; Kuznetsova, T.; Kox, M.; Zwaag, J.; et al. beta-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance. *Cell* **2016**, *167*, 1354-1368. [CrossRef] [PubMed]

129. Marinescu, V.D.; Kohane, I.S.; Riva, A. The MAPPER database: A multi-genome catalog of putative transcription factor binding sites. *Nucleic Acids Res.* **2005**, *33*, D91-D97. [CrossRef] [PubMed]

130. Roy, S.; Schmeier, S.; Arner, E.; Alam, T.; Parihar, S.P.; Ozturk, M.; Tamgue, O.; Kawaji, H.; de Hoon, M.J.; Itoh, M.; et al. Redefining the transcriptional regulatory dynamics of classically and alternatively activated macrophages by deepCAGE transcriptomics. *Nucleic Acids Res.* **2015**, *43*, 6969-6982. [CrossRef] [PubMed]

131. Suzuki, H.; Forrest, A.R.; van Nimwegen, E.; Daub, C.O.; Balwierz, P.J.; Irvine, K.M.; Lassmann, T.; Ravasi, T.; Hasegawa, Y.; de Hoon, M.J.; et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. *Nat. Genet.* **2009**, *41*, 553-562. [CrossRef] [PubMed]

132. Xue, J.; Schmidt, S.V.; Sander, J.; Draffehn, A.; Krebs, W.; Quester, I.; De Nardo, D.; Gohel, T.D.; Emde, M.; Schmidleithner, L.; et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. *Immunity* **2014**, *40*, 274-288. [CrossRef] [PubMed]

133. Drouin, J. Minireview: Pioneer transcription factors in cell fate specification. *Mol. Endocrinol.* **2014**, *28*, 989-998. [CrossRef] [PubMed]

134. Iwafuchi-Doi, M.; Zaret, K.S. Pioneer transcription factors in cell reprogramming. *Genes Dev.* **2014**, *28*, 2679-2692. [CrossRef] [PubMed]

135. Salci, K.R.; McIntyre, B.A.; Bhatia, M. Foundational concepts of cell fate conversion to the hematopoietic lineage. *Curr. Opin. Genet. Dev.* **2013**, *23*, 585-590. [CrossRef] [PubMed]
136. Ebina, W.; Rossi, D.J. Transcription factor-mediated reprogramming toward hematopoietic stem cells. *EMBO J.* **2015**, *34*, 694–709. [CrossRef] [PubMed]

137. Ginhoux, F.; Guilliams, M. Tissue-Resident Macrophage Ontogeny and Homeostasis. *Immunity* **2016**, *44*, 439–449. [CrossRef] [PubMed]

138. McGrath, K.E.; Frame, J.M.; Fegan, K.H.; Bowen, J.R.; Conway, S.J.; Catherman, S.C.; Kingsley, P.D.; Koniski, A.D.; Palis, J. Distinct Sources of Hematopoietic Progenitors Emerge before HSCs and Provide Functional Blood Cells in the Mammalian Embryo. *Cell Rep.* **2015**, *11*, 1892–1904. [CrossRef] [PubMed]

139. Cauchy, P.; James, S.R.; Zacarias-Cabeza, J.; Ptasinska, A.; Imperato, M.R.; Assi, S.A.; Piper, J.; Canestraro, M.; Hoogenkamp, M.; Raghavan, M.; et al. Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature. *Cell Rep.* **2015**, *12*, 821–836. [CrossRef] [PubMed]

140. Eriksson, A.; Lennartsson, A.; Lehmann, S. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis. *Exp. Hematol.* **2015**, *43*, 609–624. [CrossRef] [PubMed]

141. Sotoca, A.M.; Prange, K.H.; Reijnders, B.; Mandoli, A.; Nguyen, L.N.; Stunnenberg, H.G.; Martens, J.H. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia. *Oncogene* **2016**, *35*, 1965–1976. [CrossRef] [PubMed]

142. Li, Y.; Wang, H.; Wang, X.; Jin, W.; Tan, Y.; Fang, H.; Chen, S.; Chen, Z.; Wang, K. Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia. *Blood* **2016**, *127*, 233–242. [CrossRef] [PubMed]

143. Trombly, D.J.; Whitfield, T.W.; Padmanabhan, S.; Gordon, J.A.; Lian, J.B.; van Wijnen, A.J.; Zaidi, S.K.; Stein, J.L.; Stein, G.S. Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells. *BMC Genom.* **2015**, *16*, 309. [CrossRef] [PubMed]

144. Mandoli, A.; Singh, A.A.; Jansen, P.W.; Wierenga, A.T.; Riahi, H.; Franci, G.; Prange, K.; Saeed, S.; Vellenga, E.; Vermeulen, M.; et al. CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia. *Leukemia* **2014**, *28*, 770–778. [CrossRef] [PubMed]

145. Tober, J.; Yzaguirre, A.D.; Piwarzyk, E.; Speck, N.A. Distinct temporal requirements for Runx1 in hematopoietic progenitors and stem cells. *Development* **2013**, *140*, 3765–3776. [CrossRef] [PubMed]

146. Lanotte, M.; Martin-Thouvenin, V.; Najman, S.; Balerini, P.; Valensi, F.; Berger, R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). *Blood* **1991**, *77*, 1080–1086. [PubMed]

147. Brent, M.R. Past Roadblocks and New Opportunities in Transcription Factor Network Mapping. *Trends Genet.* **2016**, *32*, 736–750. [CrossRef] [PubMed]

148. Frank, C.L.; Manandhar, D.; Gordan, R.; Crawford, G.E. HDAC inhibitors cause site-specific chromatin remodeling at PU.1-bound enhancers in K562 cells. *Epigenet. Chromatin* **2016**, *9*, 15. [CrossRef] [PubMed]

149. Carlin, L.M.; Stamatiades, E.G.; Auffray, C.; Hanna, R.N.; Glover, L.; Vizcay-Barrena, G.; Hedrick, C.C.; Cook, H.T.; Diebold, S.; Geissmann, F. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. *Cell* **2013**, *153*, 362–375. [CrossRef] [PubMed]

150. Thomas, G.; Tacke, R.; Hedrick, C.C.; Hanna, R.N. Nonclassical patrolling monocyte function in the vasculature. *Arterioscler. Thromb. Vasc. Biol.* **2015**, *35*, 1306–1316. [CrossRef] [PubMed]

151. Thomas, G.D.; Hanna, R.N.; Vasudevan, N.T.; Hamers, A.A.; Romanoski, C.E.; McArdle, S.; Ross, K.D.; Blatchley, A.; Yoakum, D.; Hamilton, B.A.; et al. Deleting an Nr4a1 Super-Enhancer Subdomain Ablates Ly6Clow Monocytes while Preserving Macrophage Gene Function. *Immunity* **2016**, *45*, 975–987. [CrossRef] [PubMed]

152. Schmidl, C.; Renner, K.; Peter, K.; Eder, R.; Lassmann, T.; Balwierz, P.J.; Itoh, M.; Nagao-Sato, S.; Kawaji, H.; Carninci, P.; et al. Transcription and enhancer profiling in human monocyte subsets. *Blood* **2014**, *123*, e90–e99. [CrossRef] [PubMed]

153. Gammella, E.; Buratti, P.; Cairo, G.; Recalcati, S. Macrophages: Central regulators of iron balance. *Metallomics* **2014**, *6*, 1336–1345. [CrossRef] [PubMed]

154. Ganz, T. Macrophages and Iron Metabolism. *Microbiol. Spectr.* **2016**, *4*. [CrossRef]

155. Rawat, P.; Kumar, S.; Sheokand, N.; Raje, C.I.; Raje, M. The multifunctional glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a novel macrophage lactoferrin receptor. *Biochem. Cell Biol.* **2012**, *90*, 329–338. [CrossRef] [PubMed]
156. Zhang, F.; Tao, Y.; Zhang, Z.; Guo, X.; An, P.; Shen, Y.; Wu, Q.; Yu, Y.; Wang, F. Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responses. *Haematologica* **2012**, *97*, 1826–1835. [CrossRef] [PubMed]

157. Jacolot, S.; Yang, Y.; Paitry, P.; Ferec, C.; Mura, C. Iron metabolism in macrophages from HFE hemochromatosis patients. *Mol. Genet. Metab.* **2010**, *101*, 258–267. [CrossRef] [PubMed]

158. Venkatachalam, K.; Wong, C.O.; Zhu, M.X. The role of TRPMLs in endolysosomal trafficking and function. *Cell Calcium* **2015**, *58*, 48–56. [CrossRef] [PubMed]

159. Dayam, R.M.; Saric, A.; Shilliday, R.E.; Botelho, R.J. The Phosphoinositide-Gated Lysosomal Ca(2+) Channel, TRPML1, Is Required for Phagosome Maturation. *Traffic* **2015**, *16*, 1010–1026. [CrossRef] [PubMed]

160. White, C.; Yuan, X.; Schmidt, P.J.; Bresciani, E.; Samuel, T.K.; Campagna, D.; Hall, C.; Bishop, K.; Calicchio, M.L.; Lapierre, A.; et al. HRG1 is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis. *Cell Metab.* **2013**, *17*, 261–270. [CrossRef] [PubMed]

161. Schaer, C.A.; Vallelian, F.; Imhof, A.; Schoedon, G.; Schaer, D.J. Heme carrier protein (HCP-1) spatially interacts with the CD163 hemoglobin uptake pathway and is a target of inflammatory macrophage activation. *J. Leukoc. Biol.* **2008**, *83*, 325–333. [CrossRef] [PubMed]

162. Duffy, S.P.; Shing, J.; Saraon, P.; Berger, L.C.; Eiden, M.V.; Wilde, A.; Tailor, C.S. The Fowler syndrome-associated protein FLVCR2 is an importer of heme. *Mol. Cell. Biol.* **2010**, *30*, 5318–5324. [CrossRef] [PubMed]

163. Frey, A.G.; Nandal, A.; Park, J.H.; Smith, P.M.; Yabe, T.; Ryu, M.S.; Ghosh, M.C.; Lee, J.; Rouault, T.A.; Park, M.H.; et al. Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase. *Proc. Natl. Acad. Sci. USA* **2014**, *111*, 8031–8036. [CrossRef] [PubMed]

164. Dowdle, W.E.; Nyfeler, B.; Nagel, J.; Elling, R.A.; Liu, S.; Triantafellow, E.; Menon, S.; Wang, Z.; Honda, A.; Pardee, G.; et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. *Nat. Cell Biol.* **2014**, *16*, 1069–1079. [CrossRef] [PubMed]

165. Mancias, J.D.; Wang, X.; Gygi, S.P.; Harper, J.W.; Kimmelman, A.C. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. *Nature* **2014**, *509*, 105–109. [CrossRef] [PubMed]

166. Keel, S.B.; Doty, R.T.; Yang, Z.; Quigley, J.G.; Chen, J.; Knoblaugh, S.; Kingsley, P.D.; De Domenico, I.; Vaughn, M.B.; Kaplan, J.; et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. *Science* **2008**, *319*, 825–828. [CrossRef] [PubMed]

167. Nakashige, T.G.; Zhang, B.; Krebs, C.; Nolan, E.M. Human calprotectin is an iron-sequestering host-defense protein. *Nat. Chem. Biol.* **2015**, *11*, 765–771. [CrossRef] [PubMed]

168. O'Neill, L.A.; Kishton, R.J.; Rathmell, J. A guide to immunometabolism for immunologists. *Nat. Rev. Immunol.* **2016**, *16*, 553–565. [CrossRef] [PubMed]

169. Rozowsky, J.; Euskirchen, G.; Auerbach, R.K.; Zhang, Z.D.; Gibson, T.; Bjornson, R.; Carriero, N.; Snyder, M.; Gerstein, M.B. PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. *Nat. Biotechnol.* **2009**, *27*, 66–75. [CrossRef] [PubMed]

170. Auerbach, R.K.; Euskirchen, G.; Rozowsky, J.; Lamarre-Vincent, N.; Moqtaderi, Z.; Lefrancois, P.; Struhl, K.; Gerstein, M.; Snyder, M. Mapping accessible chromatin regions using Sono-Seq. *Proc. Natl. Acad. Sci. USA* **2009**, *106*, 14926–14931. [CrossRef] [PubMed]

171. Krijger, P.H.; Di Stefano, B.; de Wit, E.; Limone, F.; van Oevelen, C.; de Laat, W.; Graf, T. Cell-of-Origin-Specific 3D Genome Structure Acquired during Somatic Cell Reprogramming. *Cell Stem Cell* **2016**, *18*, 597–610. [CrossRef] [PubMed]

172. Goode, D.K.; Obier, N.; Vijayabaskar, M.S.; Lie, A.L.; Lilly, A.J.; Hannah, R.; Lichtinger, M.; Batta, K.; Florkowska, M.; Patel, R.; et al. Dynamic Gene Regulatory Networks Drive Hematopoietic Specification and Differentiation. *Dev. Cell* **2016**, *36*, 572–587. [CrossRef] [PubMed]

173. Yue, F.; Cheng, Y.; Breschi, A.; Vierstra, J.; Wu, W.; Ryba, T.; Sandstrom, R.; Ma, Z.; Davis, C.; Pope, B.; et al. A comparative encyclopedia of DNA elements in the mouse genome. *Nature* **2014**, *515*, 355–364. [CrossRef] [PubMed]

174. Luyten, A.; Zang, C.; Liu, X.S.; Shivdasani, R.A. Active enhancers are delineated de novo during hematopoiesis, with limited lineage fidelity among specified primary blood cells. *Genes Dev.* **2014**, *28*, 1827–1839. [CrossRef] [PubMed]
175. Paul, F.; Arkin, Y.; Giladi, A.; Jaitin, D.A.; Kenigsberg, E.; Keren-Shaul, H.; Winter, D.; Lara-Astiaso, D.; Gury, M.; Weiner, A.; et al. Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors. *Cell* **2015**, *163*, 1663-1677. [CrossRef] [PubMed]

176. Ferri, F.; Parceler, A.; Petit, V.; Gallouet, A.S.; Lewandowski, D.; Dalloz, M.; van den Heuvel, A.; Kolovos, P.; Soler, E.; Squadrito, M.L.; et al. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation. *Nat. Commun.* **2015**, *6*, 8900. [CrossRef] [PubMed]

177. Langlais, D.; Barreiro, L.B.; Gros, P. The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation. *J. Exp. Med.* **2016**, *213*, 585-603. [CrossRef] [PubMed]

178. Matcovitch-Natan, O.; Winter, D.R.; Giladi, A.; Vargas, A.S.; Spinrad, A.; Sarrazin, S.; Ben-Yehuda, H.; David, E.; Zelada, G.F.; Perrin, P.; et al. Microglia development follows a stepwise program to regulate brain homeostasis. *Science* **2016**, *353*, aad8670. [CrossRef] [PubMed]

179. Govoni, G.; Gauthier, S.; Billia, F.; Iscove, N.N.; Gros, P. Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. *J. Leukoc. Biol.* **1997**, *62*, 277-286. [PubMed]

180. Weiner, A.; Lara-Astiaso, D.; Krupalnik, V.; Gafni, O.; David, E.; Winter, D.R.; Hanna, J.H.; Amit, I. Co-ChIP enables genome-wide mapping of histone mark co-occurrence at single-molecule resolution. *Nat. Biotechnol.* **2016**, *34*, 953-961. [CrossRef] [PubMed]

181. Kumar, V.; Rayan, N.A.; Muratani, M.; Lim, S.; Elanggovan, B.; Xin, L.; Lu, T.; Makhija, H.; Poschmann, J.; Lufkin, T.; et al. Comprehensive benchmarking reveals H2BK20 acetylation as a distinctive signature of cell-state-specific enhancers and promoters. *Genome Res.* **2016**, *26*, 612-623. [CrossRef] [PubMed]

182. Tong, A.J.; Liu, X.; Thomas, B.J.; Lissner, M.M.; Baker, M.R.; Senagolage, M.D.; Allred, A.L.; Barish, G.D.; Smale, S.T. A Stringent Systems Approach Uncovers Gene-Specific Mechanisms Regulating Inflammation. *Cell* **2016**, *165*, 165-179. [CrossRef] [PubMed]

183. Bhagwat, A.S.; Roe, J.S.; Mok, B.Y.; Hohmann, A.F.; Shi, J.; Vakoc, C.R. BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements. *Cell Rep.* **2016**, *15*, 519-530. [CrossRef] [PubMed]

184. Hasemann, M.S.; Lauridsen, F.K.; Waage, J.; Jakobsen, J.S.; Frank, A.K.; Schuster, M.B.; Rapin, N.; Bagger, F.O.; Hoppe, P.S.; Schroeder, T.; et al. C/EBPalpha is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors. *PLoS Genet.* **2014**, *10*, e1004079. [CrossRef] [PubMed]

185. Zhang, H.; Alberich-Jorda, M.; Amabile, G.; Yang, H.; Staber, P.B.; Di Ruscio, A.; Welner, R.S.; Ebralidze, A.; Zhang, J.; Levantini, E.; et al. Sox4 is a key oncogenic target in C/EBPalpha mutant acute myeloid leukemia. *Cancer Cell* **2013**, *24*, 575-588. [CrossRef] [PubMed]

186. Kumar, R.; Fossati, V.; Israel, M.; Snoeck, H.W. Lin-Sca1+kit-bone marrow cells contain early lymphoid-committed precursors that are distinct from common lymphoid progenitors. *J. Immunol.* **2008**, *181*, 7507-7513. [CrossRef] [PubMed]

187. Kurotaki, D.; Osato, N.; Nishiyama, A.; Yamamoto, M.; Ban, T.; Sato, H.; Nakabayashi, J.; Umehara, M.; Miyake, N.; Matsumoto, N.; et al. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. *Blood* **2013**, *121*, 1839-1849. [CrossRef] [PubMed]

188. KC, W.; Satpathy, A.T.; Rapaport, A.S.; Briseno, C.G.; Wu, X.; Albring, J.C.; Russler-Germain, E.V.; Kretzer, N.M.; Durai, V.; Persaud, S.P.; et al. L-Myc expression by dendritic cells is required for optimal T-cell priming. *Nature* **2014**, *507*, 243-247. [CrossRef] [PubMed]

189. Tamura, T.; Nagamura-Inoue, T.; Shmeltzer, Z.; Kuwata, T.; Ozato, K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. *Immunity* **2000**, *13*, 155-165. [CrossRef]

190. Yanez, A.; Goodridge, H.S. Interferon regulatory factor 8 and the regulation of neutrophil, monocyte, and dendritic cell production. *Curr. Opin. Hematol.* **2016**, *23*, 11-17. [CrossRef] [PubMed]

191. Oishi, Y.; Spann, N.J.; Link, V.M.; Muse, E.D.; Strid, T.; Edillor, C.; Kolar, M.J.; Matsuzaka, T.; Hayakawa, S.; Tao, J.; et al. SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism. *Cell Metab.* **2017**, *25*, 412-427. [CrossRef] [PubMed]

192. Villar, D.; Berthelot, C.; Aldridge, S.; Rayner, T.F.; Lukk, M.; Pignatelli, M.; Park, T.J.; Deaville, R.; Erichsen, J.T.; Jasinska, A.J.; et al. Enhancer evolution across 20 mammalian species. *Cell* **2015**, *160*, 554-566. [CrossRef] [PubMed]

193. Van den Bosch, T.; Boichenko, A.; Leus, N.G.; Ourailidou, M.E.; Wapenaar, H.; Rotili, D.; Mai, A.; Imhof, A.; Bischoff, R.; Haisma, H.J.; et al. The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases. *Biochem. Pharmacol.* **2016**, *102*, 130-140. [CrossRef] [PubMed]
194. Netea, M.G.; Joosten, L.A.; Latz, E.; Mills, K.H.; Natoli, G.; Stunnenberg, H.G.; O'Neill, L.A.; Xavier, R.J. Trained immunity: A program of innate immune memory in health and disease. *Science* **2016**, *352*, aaf1098.
[CrossRef] [PubMed]

195. Tacchini, L.; Gammella, E.; De Ponti, C.; Recalcati, S.; Cairo, G. Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. *J. Biol. Chem.* **2008**, *283*, 20674-20686. [CrossRef] [PubMed]

196. Glass, C.K. Genetic and genomic approaches to understanding macrophage identity and function. *Arterioscler. Thromb. Vasc. Biol.* **2015**, *35*, 755-762. [CrossRef] [PubMed]

197. Fattahi-Dolatabadi, M.; Mousavi, T.; Mohammadi-Barzelighi, H.; Irian, S.; Bakhshi, B.; Nilforoushzadeh, M.A.; Shirani-Bidabadi, L.; Hariri, M.M.; Ansari, N.; Akbari, N. *NRAMP1* gene polymorphisms and cutaneous leishmaniasis: An evaluation on host susceptibility and treatment outcome. *J. Vector Borne Dis.* **2016**, *53*, 257-263. [PubMed]

198. Kadkhodazadeh, M.; Ebadian, A.R.; Amid, R.; Zarnegarnia, P.; Mollaverdi, F.; Aghamohammadi, N. *Natural Resistance Associated Macrophage Protein 1* Gene Polymorphism is Associated with Chronic Periodontitis Not Peri-Implantitis in an Iranian Population: A Cross Sectional Study. *Acta Med. Iran.* **2016**, *54*, 323-329.
[PubMed]

199. Brochado, M.J.; Gatti, M.F.; Zago, M.A.; Roselino, A.M. Association of the solute carrier family 11 member 1 gene polymorphisms with susceptibility to leprosy in a Brazilian sample. *Mem. Inst. Oswaldo Cruz.* **2016**, *111*, 101-105. [CrossRef] [PubMed]

200. Niño-Moreno, P.; Turrubiartes-Martínez, E.; Oceguera-Maldonado, B.; Baltazar-Benítez, N.; Negrete-González, C.; Oliva-Ramírez, B.; Baranda, L.; González-Amaro, R. The Role of NRAMP1/SLC11A1 Gene Variant D543N (1730G/A) in the Genetic Susceptibility to Develop Rheumatoid Arthritis in the Mexican Mestizo population. *Rev. Investig. Clin.* **2017**, *69*, 5-10.

201. Gorenshteyn, D.; Zaslavsky, E.; Fribourg, M.; Park, C.Y.; Wong, A.K.; Tadych, A.; Hartmann, B.M.; Albrecht, R.A.; Garcia-Sastre, A.; Kleinstein, S.H.; et al. Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases. *Immunity* **2015**, *43*, 605-614. [CrossRef] [PubMed]

202. Dey, G.; Jaimovich, A.; Collins, S.R.; Seki, A.; Meyer, T. Systematic Discovery of Human Gene Function and Principles of Modular Organization through Phylogenetic Profiling. *Cell Rep.* **2015**, *10*, 993-1006. [CrossRef] [PubMed]

<figure><img src="image_14.png" /></figure>

© 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).